Cambridge Investment Research Advisors’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
6,094
+250
+4% +$36.6K ﹤0.01% 2253
2026
Q1
$720K Buy
5,844
+447
+8% +$58.7K ﹤0.01% 2465
2025
Q4
$708K Buy
5,397
+26
+0.5% +$3.05K ﹤0.01% 2410
2025
Q3
$510K Buy
5,371
+144
+3% +$14.3K ﹤0.01% 2667
2025
Q2
$499K Buy
5,227
+554
+12% +$45K ﹤0.01% 2548
2025
Q1
$371K Buy
4,673
+404
+9% +$43.7K ﹤0.01% 2694
2024
Q4
$570K Buy
4,269
+572
+15% +$81.5K ﹤0.01% 2314
2024
Q3
$482K Sell
3,697
-1,600
-30% -$197K ﹤0.01% 2447
2024
Q2
$553K Sell
5,297
-10,460
-66% -$1.17M ﹤0.01% 2217
2024
Q1
$2.1M Sell
15,757
-2,044
-11% -$274K 0.01% 1229
2023
Q4
$2.41M Buy
17,801
+10,196
+134% +$1.18M 0.01% 1090
2023
Q3
$1.02M Buy
7,605
+2,321
+44% +$382K ﹤0.01% 1571
2023
Q2
$964K Buy
5,284
+949
+22% +$192K ﹤0.01% 1637
2023
Q1
$981K Sell
4,335
-2,062
-32% -$422K ﹤0.01% 1589
2022
Q4
$1.26M Sell
6,397
-2,975
-32% -$617K 0.01% 1360
2022
Q3
$1.74M Sell
9,372
-402
-4% -$79.5K 0.01% 1110
2022
Q2
$1.75M Buy
9,774
+1,582
+19% +$404K 0.01% 1112
2022
Q1
$2.78M Sell
8,192
-2,734
-25% -$923K 0.01% 957
2021
Q4
$4.04M Buy
10,926
+3,094
+40% +$1.17M 0.02% 745
2021
Q3
$3.09M Sell
7,832
-361
-4% -$166K 0.02% 854
2021
Q2
$3.77M Buy
8,193
+681
+9% +$274K 0.02% 763
2021
Q1
$2.81M Sell
7,512
-1,335
-15% -$544K 0.02% 836
2020
Q4
$3.18M Buy
8,847
+3,371
+62% +$1.07M 0.02% 685
2020
Q3
$1.65M Sell
5,476
-880
-14% -$303K 0.01% 907
2020
Q2
$2.29M Sell
6,356
-971
-13% -$312K 0.02% 712
2020
Q1
$1.95M Buy
7,327
+539
+8% +$151K 0.02% 677
2019
Q4
$2.19M Buy
6,788
+136
+2% +$41.2K 0.02% 746
2019
Q3
$1.97M Sell
6,652
-523
-7% -$154K 0.02% 757
2019
Q2
$2.57M Sell
7,175
-560
-7% -$177K 0.02% 625
2019
Q1
$2.34M Buy
7,735
+452
+6% +$132K 0.02% 654
2018
Q4
$2.13M Buy
7,283
+775
+12% +$240K 0.02% 617
2018
Q3
$2.32M Buy
6,508
+3,037
+87% +$973K 0.02% 628
2018
Q2
$943K Sell
3,471
-1,538
-31% -$391K 0.01% 1017
2018
Q1
$1.15M Buy
5,009
+1,605
+47% +$368K 0.01% 864
2017
Q4
$723K Sell
3,404
-225
-6% -$46.3K 0.01% 1086
2017
Q3
$703K Sell
3,629
-7,111
-66% -$1.32M 0.01% 1023
2017
Q2
$1.81M Buy
10,740
+8,047
+299% +$1.39M 0.03% 559
2017
Q1
$447K Sell
2,693
-67
-2% -$10.6K 0.01% 1130
2016
Q4
$344K Sell
2,760
-60
-2% -$8.09K 0.01% 1204
2016
Q3
$498K Sell
2,820
-111
-4% -$17.8K 0.01% 1035
2016
Q2
$400K Buy
2,931
+417
+17% +$59.2K 0.01% 1045
2016
Q1
$397K Buy
2,514
+148
+6% +$22.6K 0.01% 1024
2015
Q4
$442K Sell
2,366
-1,357
-36% -$219K 0.01% 905
2015
Q3
$637K Sell
3,723
-1,149
-24% -$232K 0.02% 651
2015
Q2
$1.03M Sell
4,872
-56
-1% -$10.9K 0.03% 497
2015
Q1
$890K Buy
4,928
+1,429
+41% +$269K 0.03% 545
2014
Q4
$628K Sell
3,499
-178
-5% -$31.4K 0.02% 661
2014
Q3
$586K Buy
3,677
+115
+3% +$19.2K 0.02% 734
2014
Q2
$619K Buy
3,562
+196
+6% +$29.2K 0.02% 648
2014
Q1
$487K Sell
3,366
-2,282
-40% -$335K 0.02% 724
2013
Q4
$608K Buy
5,648
+58
+1% +$5.31K 0.02% 575
2013
Q3
$440K Buy
5,590
+15
+0.3% +$1.15K 0.02% 687
2013
Q2
$406K Buy
+5,575
New +$357K 0.02% 632

Other funds holding ILMN

Cambridge Investment Research Advisors's ILMN Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Illumina (ILMN) stake by 4.3% in Q2 2026, buying an estimated $36.6K and bringing the position to 6,094 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2253.

Cambridge Investment Research Advisors first reported a position in ILMN in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.04M in Q4 2021. 933 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • Cambridge Investment Research Advisors held 6,094 shares of Illumina worth $1.07M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 250 Illumina shares in Q2 2026, an estimated $36.6K.
  • Illumina made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2253 holding.
  • Cambridge Investment Research Advisors first reported a position in Illumina in Q2 2013 and has held it in 53 quarters since.
  • Cambridge Investment Research Advisors's Illumina position peaked at $4.04M in Q4 2021.
  • 933 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.